Patent · US Active

Substituted N-heterocyclic compounds and their use as dopamine D3 receptor ligands

US8114875B2 · kind B2 · utility

0Cited by

0References

9Claims

0Family size

Assignee

Abbott GmbH & Co. KG · DE

Inventors

Hervé Geneste · Schifferstadt, DE
Daryl Sauer · Pleasant Prairie, US

Key dates

Filing date	Dec 20, 2005
Grant date	Feb 14, 2012
Priority date	—
Expiry date	Oct 17, 2026

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D409/12
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The invention relates to substituted N-heterocyclic compounds of general formula (I.A)and to the tautomers of the compounds the physiologically acceptable salts of the compounds and the physiologically acceptable salts of the tautomers of the compounds. The invention also relates to the use of these compounds and their pharmacologically acceptable salts in the production of a pharmaceutical agent for treating diseases that respond to the influence exerted by dopamine D3 receptor ligands, especially for treating diseases of the central nervous system, especially schizophrenia and/or depression.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.